相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Developmental patterns in human blood-brain barrier and blood-cerebrospinal fluid barrier ABC drug transporter expression
L. F. M. Verscheijden et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2020)
Imaging P-Glycoprotein Function at the Blood-Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs
Martin Bauer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited
Ahmad Al‐Saffar et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Response to Impact of Acute Alcohol Exposure on P-Glycoprotein Function at the Blood-Brain Barrier Assessed Using 11C-Metoclopramide PET Imaging
Chih-hsuan Hsin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans
Nicolas Tournier et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
Verena Pichler et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
Yijun Pan et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of C-11-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman Primates
Sylvain Auvity et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank
Helmuth Haslacher et al.
BIOPRESERVATION AND BIOBANKING (2018)
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11C]verapamil in elderly vs. young subjects
Martin Bauer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide
Geraldine Pottier et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain Barrier
M. Bauer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
Stefan Wolking et al.
CLINICAL PHARMACOKINETICS (2015)
P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations
Catherine Chiu et al.
NEUROBIOLOGY OF AGING (2015)
The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates
Jessica Lam et al.
PEDIATRIC RESEARCH (2015)
Utility of Cerebrospinal Fluid Drug Concentration as a Surrogate for Unbound Brain Concentration in Nonhuman Primates
Yoko Nagaya et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Tardive and spontaneous dyskinesia incidence in the general population
Ray M. Merrill et al.
BMC PSYCHIATRY (2013)
Clinical Response and Side Effects of Metoclopramide Associations With Clinical, Demographic, and Pharmacogenetic Parameters
Henry P. Parkman et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Structural Studies on D2 Dopamine Receptors: Mutation of a Histidine Residue Specifically Affects the Binding of a Subgroup of Substituted Benzamide Drugs
Robert Woodward et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies
Upendra A. Argikar et al.
DRUG METABOLISM AND DISPOSITION (2010)
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
Anna L. Bartels et al.
NEUROBIOLOGY OF AGING (2009)
MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells
Noha N. Salama et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of ( R )-[11C]verapamil and positron emission tomography
Rolf Toornvliet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Drug Insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide
PJ Pasricha et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model
A Doran et al.
DRUG METABOLISM AND DISPOSITION (2005)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6
Z Desta et al.
DRUG METABOLISM AND DISPOSITION (2002)
分享论文
